ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 1206

$746K Total Retail Price of All Prescriptions

Rank: 36 out of 1206

121 Patients Receiving at Least One Drug in Part D
18%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 121 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 1,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

78 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
POLYETHYLENE GLYCOL 3350 687 84 1 31
NEXIUM 615 95 2 47
LACTULOSE 484 54 3 124
LEVOTHYROXINE SODIUM 471 62 4 2
IBANDRONATE SODIUM 315 45 10 5 218
BONIVA 221 31 6 226
RISPERIDONE 219 54 7 74
CARBAMAZEPINE 215 39 8 146
DILANTIN 201 20 9 192
LAMOTRIGINE 152 55 10 162
BACLOFEN 149 0 11 137
FLUTICASONE PROPIONATE 143 21 12 42
DIVALPROEX SODIUM ER 132 0 13 163
PANTOPRAZOLE SODIUM 129 18 14 54
NASONEX 123 23 15 251
LEVETIRACETAM 110 12 16 135
RANITIDINE HCL 101 44 17 23
VALPROIC ACID 99 0 18 241
METOCLOPRAMIDE HCL 98 55 19 127
TOPIRAMATE 97 0 20 168
CHLORHEXIDINE GLUCONATE 93 0 21 188
ATORVASTATIN CALCIUM 85 0 22 13
POTASSIUM CHLORIDE 84 0 23 12
METOPROLOL TARTRATE 84 27 23 9
OXCARBAZEPINE 81 0 25 240
DIVALPROEX SODIUM 79 0 26 153
HALOPERIDOL 78 21 27 187
SUCRALFATE 78 18 27 143
FUROSEMIDE 77 0 29 5
CLOZAPINE 76 19 30 191
SIMVASTATIN 75 35 31 1
WATER 73 39 32 298
TRAMADOL HCL 68 0 33 17
TAMSULOSIN HCL 65 28 34 26
HYDROCHLOROTHIAZIDE 62 13 35 11
CEPHALEXIN 62 18 35 62
AMLODIPINE BESYLATE 60 12 37 6
METFORMIN HCL 58 0 38 10
MELOXICAM 57 0 39 35
QUETIAPINE FUMARATE 57 0 39 79
ESCITALOPRAM OXALATE 57 0 39 86
E.E.S. 200 56 0 42 325
OMEPRAZOLE 56 31 42 3
LISINOPRIL 55 29 44 4
AMITIZA 55 14 44 326
LITHIUM CARBONATE 54 0 46 268
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.